These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 26088748)

  • 1. Estimating the risk of chemotherapy toxicity in older patients with cancer: The role of the Vulnerable Elders Survey-13 (VES-13).
    Luciani A; Biganzoli L; Colloca G; Falci C; Castagneto B; Floriani I; Battisti N; Dottorini L; Ferrari D; Fiduccia P; Zafarana E; Del Monte F; Galli F; Monfardini S; Foa P
    J Geriatr Oncol; 2015 Jul; 6(4):272-9. PubMed ID: 26088748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Cancer treatment in elderly patients: evidence and clinical research].
    Repetto L; Luciani A
    Recenti Prog Med; 2015 Jan; 106(1):23-7. PubMed ID: 25621776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A pilot study of the vulnerable elders survey-13 compared with the comprehensive geriatric assessment for identifying disability in older patients with prostate cancer who receive androgen ablation.
    Mohile SG; Bylow K; Dale W; Dignam J; Martin K; Petrylak DP; Stadler WM; Rodin M
    Cancer; 2007 Feb; 109(4):802-10. PubMed ID: 17219443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Can Vulnerable Elders Survey-13 predict the impact of frailty on chemotherapy in elderly patients with gynaecological malignancies?
    Ferrero A; Villa M; Tripodi E; Fuso L; Menato G
    Medicine (Baltimore); 2018 Sep; 97(39):e12298. PubMed ID: 30278504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detecting disabilities in older patients with cancer: comparison between comprehensive geriatric assessment and vulnerable elders survey-13.
    Luciani A; Ascione G; Bertuzzi C; Marussi D; Codecà C; Di Maria G; Caldiera SE; Floriani I; Zonato S; Ferrari D; Foa P
    J Clin Oncol; 2010 Apr; 28(12):2046-50. PubMed ID: 20308657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictive value of geriatric assessment for patients older than 70 years, treated with chemotherapy.
    Aaldriks AA; Maartense E; le Cessie S; Giltay EJ; Verlaan HA; van der Geest LG; Kloosterman-Boele WM; Peters-Dijkshoorn MT; Blansjaar BA; van Schaick HW; Nortier JW
    Crit Rev Oncol Hematol; 2011 Aug; 79(2):205-12. PubMed ID: 20709565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of the CARG tool, the VES-13, and oncologist judgment in predicting grade 3+ toxicities in men undergoing chemotherapy for metastatic prostate cancer.
    Alibhai SM; Aziz S; Manokumar T; Timilshina N; Breunis H
    J Geriatr Oncol; 2017 Jan; 8(1):31-36. PubMed ID: 27756545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vulnerable Elderly Survey 13 as a screening method for frailty in Polish elderly surgical patient--prospective study.
    Kenig J; Richter P; Zychiewicz B; Olszewska U
    Pol Przegl Chir; 2014 Mar; 86(3):126-31. PubMed ID: 24791815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Questionnaire Study to Assess the Value of the Vulnerable Elders Survey, G8, and Predictors of Toxicity as Screening Tools for Frailty and Toxicity in Geriatric Cancer Patients.
    Hentschel L; Rentsch A; Lenz F; Hornemann B; Schmitt J; Baumann M; Ehninger G; Schuler M
    Oncol Res Treat; 2016; 39(4):210-6. PubMed ID: 27160741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Performance of the Vulnerable Elders Survey 13 screening tool in identifying cancer treatment modification after geriatric assessment in pre-treatment patients: A retrospective analysis.
    Rowbottom L; Loucks A; Jin R; Breunis H; Syed AT; Watt S; Timilshina N; Puts M; Yokom D; Berger A; Alibhai SMH
    J Geriatr Oncol; 2019 Mar; 10(2):229-234. PubMed ID: 30420323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Baseline comprehensive geriatric assessment is associated with toxicity and survival in elderly metastatic breast cancer patients receiving single-agent chemotherapy: results from the OMEGA study of the Dutch breast cancer trialists' group.
    Hamaker ME; Seynaeve C; Wymenga AN; van Tinteren H; Nortier JW; Maartense E; de Graaf H; de Jongh FE; Braun JJ; Los M; Schrama JG; van Leeuwen-Stok AE; de Groot SM; Smorenburg CH
    Breast; 2014 Feb; 23(1):81-7. PubMed ID: 24314824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Completion of radiotherapy is associated with the Vulnerable Elders Survey-13 score in elderly patients with cancer.
    Spyropoulou D; Pallis AG; Leotsinidis M; Kardamakis D
    J Geriatr Oncol; 2014 Jan; 5(1):20-5. PubMed ID: 24484714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PPT and VES-13 in elderly patients with cancer: evaluation in multidimensional geriatric assessment and prediction of survival.
    Augschoell J; Kemmler G; Hamaker ME; Stauder R
    J Geriatr Oncol; 2014 Oct; 5(4):415-21. PubMed ID: 25242575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospective comparison of the value of CARG, G8, and VES-13 toxicity tools in predicting chemotherapy-related toxicity in older Turkish patients with cancer.
    Cavdar E; Iriagac Y; Karaboyun K; Avci O; Seber ES
    J Geriatr Oncol; 2022 Jul; 13(6):821-827. PubMed ID: 35361561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening for vulnerability in older cancer patients: the ONCODAGE Prospective Multicenter Cohort Study.
    Soubeyran P; Bellera C; Goyard J; Heitz D; Curé H; Rousselot H; Albrand G; Servent V; Jean OS; van Praagh I; Kurtz JE; Périn S; Verhaeghe JL; Terret C; Desauw C; Girre V; Mertens C; Mathoulin-Pélissier S; Rainfray M
    PLoS One; 2014; 9(12):e115060. PubMed ID: 25503576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional decline in older patients with cancer receiving first-line chemotherapy.
    Hoppe S; Rainfray M; Fonck M; Hoppenreys L; Blanc JF; Ceccaldi J; Mertens C; Blanc-Bisson C; Imbert Y; Cany L; Vogt L; Dauba J; Houédé N; Bellera CA; Floquet A; Fabry MN; Ravaud A; Chakiba C; Mathoulin-Pélissier S; Soubeyran P
    J Clin Oncol; 2013 Nov; 31(31):3877-82. PubMed ID: 24062399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comprehensive geriatric assessment in female elderly patients with Alzheimer disease and other types of dementia.
    Riccio D; Solinas A; Astara G; Mantovani G
    Arch Gerontol Geriatr; 2007; 44 Suppl 1():343-53. PubMed ID: 17317473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening Performance for Frailty Among Older Patients With Cancer: A Cross-Sectional Observational Study of Two Approaches.
    Okuyama T; Sugano K; Iida S; Ishida T; Kusumoto S; Akechi T
    J Natl Compr Canc Netw; 2015 Dec; 13(12):1525-31. PubMed ID: 26656521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identifying an accurate pre-screening tool in geriatric oncology.
    Kellen E; Bulens P; Deckx L; Schouten H; Van Dijk M; Verdonck I; Buntinx F
    Crit Rev Oncol Hematol; 2010 Sep; 75(3):243-8. PubMed ID: 20060313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comprehensive Geriatric Assessment in Men Aged 70 Years or Older with Localised Prostate Cancer Undergoing Radical Radiotherapy.
    Osborne GEC; Appleyard SA; Gilbert DC; Jones CI; Lorimer C; Villanueva M; Peasgood E; Robinson A; Nikapota A; Ring A
    Clin Oncol (R Coll Radiol); 2017 Sep; 29(9):609-616. PubMed ID: 28592379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.